Search

Search Constraints

You searched for: Author/Creator Booth, Kevin

Search Results

1. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Issue 1 (December 2016)

2. Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab. (6th March 2018)

3. Detection and Confirmation of Deafness-Causing Copy Number Variations in the STRC Gene by Massively Parallel Sequencing and Comparative Genomic Hybridization. (November 2016)

6. Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies. Issue 1 (December 2016)

7. P1‐145: A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSES TO EVALUATE CEREBROSPINAL FLUID (CSF) PHOSPHORYLATED TAU (P‐TAU) AND TOTAL TAU (T‐TAU) AS BIOMARKERS OF ALZHEIMER'S DISEASE PROGRESSION. (1st July 2014)

8. P1‐146: A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSES TO EVALUATE BRAIN AMYLOID BY POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AS A BIOMARKER OF ALZHEIMER'S DISEASE (AD) PROGRESSION. (1st July 2014)

9. P1‐147: A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSES TO EVALUATE GLOBAL AND REGIONAL BRAIN VOLUMES BY STRUCTURAL MRI AS BIOMARKERS OF ALZHEIMER'S DISEASE (AD) PROGRESSION. (1st July 2014)